The Skin Cancer Audit & Research Database

SCARD for Life

The SCCANZ Surgical Audit Project is a surgical log designed for doctors who treat skin malignancies. It has been designed to facilitate the easy recording of useful data at the time of treatment so that the treatment of skin cancers can be tracked.

The On-line version has now superseded the previous version. There is now no need to download and install any software.

This project also facilitates the generation of a confidential report on your computer. You are able to obtain a breakdown of your specimen management details including a breakdown by diagnosis, the number of new lesions sampled to exclude melanoma to find one melanoma, the percentage of new lesions treated to exclude non-melanoma skin cancer which are malignant, your diagnostic accuracy, the percentage of definitive managements which achieve adequate margins and other relevant details.

SCARD in the International Journal of Dermatology

Measuring performance in skin cancer practice: the SCARD initiative.


Rosendahl C, Hansen C, Cameron A, Bourne P, Wilson T, Cook B, Baker M, Keir J, Dicker T, Reid M, Williamson R, Weedon D, Soyer HP, Youl PH, Wilkinson D.

School of Medicine, The University of Queensland, Brisbane, Australia. This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Read more...

The Martin Baker SCARD Melanoma Project

The Skin Cancer Audit Research Database (SCARD) project has been developed by the Skin Cancer College of Australia and New Zealand (SCCANZ). This project has accumulated a large amount of data which is being analysed in partnership with the University of Queensland for research purposes.

In this new proposed project, data will be collected using the SCARD infrastructure. This study will take the quality of data collection one step further. Completeness of data will be verified as will the entry of the Provisional Diagnosis (PD) prior to knowledge of the Histological Diagnosis (HD). Also accuracy of entered HD will be independently verified by the pathology provider.

Read More about the Martin Baker Study